<--- Back to Details
First PageDocument Content
Gastrointestinal cancer / Cancer / Occupational safety and health / Pathology / Breast cancer / Prostate cancer / Liver cancer / Stomach cancer / Human papillomavirus / Medicine / Oncology / Carcinogens
Date: 2015-03-03 07:24:03
Gastrointestinal cancer
Cancer
Occupational safety and health
Pathology
Breast cancer
Prostate cancer
Liver cancer
Stomach cancer
Human papillomavirus
Medicine
Oncology
Carcinogens

Cancer cases set to rise by half by 2030

Add to Reading List

Source URL: medicalxpress.com

Download Document from Source Website

File Size: 17,61 KB

Share Document on Facebook

Similar Documents

Journal of Machine Learning ResearchSubmitted 8/15; Revised 3/16; PublishedStructure-Leveraged Methods in Breast Cancer Risk Prediction

DocID: 1vq0d - View Document

Multicausality: Confounding - Assignment solutions 1. a. Reserpine is a risk factor. Overall, the incidence of breast cancer isper 100,000 women-years in reserpine users and 6.14 per 100,000 women-years in nonuser

DocID: 1vpNA - View Document

Frequently Asked Questions: Trainees seeking a PhD education in Cancer Biology or a related area with a focus on Breast Cancer Health Disparities. 1. What is the Komen Graduate Training in Disparities Research Grant (GT

DocID: 1voV1 - View Document

_____________________________________________________________ What to Do When Someone You Know Has Been Diagnosed with Breast Cancer [Last revised Mar 2014]

DocID: 1vlqg - View Document

Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1–mediated metabolism to the product 4′ hydroxy tangeretin

DocID: 1vl9e - View Document